Patient flow
Depression, Anxiety, IPF, CTD-ILD
LUNG, INTERSTITIAL LUNG DISEASE, HYPERSENSITIVITY PNEUMONITIS, IDIOPATHIC PULMONARY FIBROSIS
Sixty participants consented to the study but two participants withdrew prior to commencement of the PR programme. A total of 58 participants started the PR programme. Consolidated Standards of Reporting Trials diagram of participants’ flow in the study. CHP, chronic hypersensitivity pneumonitis; CTD-ILD, connective tissue disease-related interstitial lung disease; HIIT, high-intensity interval training; ILD, interstitial lung disease; ILD-PR, pulmonary rehabilitation programme tailored for patients with interstitial lung disease; IPF, idiopathic pulmonary fibrosis; MICT, moderate-intensity continuous training; PR, pulmonary rehabilitation.Baseline characteristics are shown in Baseline characteristicsData are means (SD) unless otherwise stated. The p value tests the general null hypothesis of similarity between the randomised groups. The methods include t-tests (equal or unequal variances), Kruskal-Wallis and χ* P value was calculated considering the whole (balanced) distribution.BMI, body mass index; CHP, chronic hypersensitivity pneumonitis; CTD-ILD, connective tissue disease-related interstitial lung disease; DLCO, Diffusion capacity of lung for carbon monoxide; FVC, forced vital capacity; HAD-A, Hospital Anxiety and Depression scale- Anxiety total score; HAD-D, Hospital Anxiety and Depression scale- Depression total score; ILD, interstitial lung disease; ILD-GAP index, Interstitial Lung Disease-Gender (G), Age (A) and lung physiology (P) variables (FVC and DLCO) point-scoring system.; IPF, idiopathic pulmonary fibrosis; LTOT, long-term oxygen therapy; 6MWD, 6 min walk distance; PEmax, maximal expiratory pressure; PImax, maximal inspiratory pressure; SGRQ-I, St George’s Respiratory Questionnaire for IPF; SNIP, sniff nasal pressure.